US20160067498A1 - Determining onsets and offsets of cardiac depolarization and repolarization waves - Google Patents
Determining onsets and offsets of cardiac depolarization and repolarization waves Download PDFInfo
- Publication number
- US20160067498A1 US20160067498A1 US14/853,640 US201514853640A US2016067498A1 US 20160067498 A1 US20160067498 A1 US 20160067498A1 US 201514853640 A US201514853640 A US 201514853640A US 2016067498 A1 US2016067498 A1 US 2016067498A1
- Authority
- US
- United States
- Prior art keywords
- signal
- onset
- depolarization
- curvature
- point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36507—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by gradient or slope of the heart potential
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/282—Holders for multiple electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0036—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room including treatment, e.g., using an implantable medical device, ablating, ventilating
-
- A61B5/04085—
-
- A61B5/0452—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1107—Measuring contraction of parts of the body, e.g. organ, muscle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/043—Arrangements of multiple sensors of the same type in a linear array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium
- A61N1/36842—Multi-site stimulation in the same chamber
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Signal Processing (AREA)
Abstract
An exemplary computer-implemented method is disclosed for detection of onset of depolarization on far-field electrograms (EGMs) or electrocardiogram (ECG)-or ECG-like signals. The method includes determining a baseline rhythm using a plurality of body-surface electrodes. The baseline rhythm includes an atrial marker and a ventricular marker. A pre-specified window is defined as being between the atrial marker and the ventricular marker. A low pass filter is applied to a signal within the window. A rectified slope of the signal within the window is determined. A determination is made as to whether a time point (t1) is present such that the rectified slope exceeds 10% of a maximum value of the rectified slope. A point of onset of a depolarization complex in the signal is determined. The point of onset occurs at a largest curvature in the signal within the window.
Description
- This application is a continuation of U.S. patent application Ser. No. 13/952,076, filed Jul. 26, 2013 entitled “DETERINING ONSETS AND OFFSETS OF CARDIAC DEPOLARIZATION AND REPOLARIZATION WAVES”, herein incorporated by reference in its entirety.
- The invention relates to medical devices, and more particular, to medical devices for sensing, detection, and analysis of cardiac electrograms and electrocardiograms.
- Implantable medical devices (IMDs), such as implantable pacemakers, cardioverters, defibrillators, or pacemaker-cardioverter-defibrillators, provide therapeutic electrical stimulation to the heart. IMDs may provide pacing to address bradycardia, or pacing or shocks in order to terminate tachyarrhythmia, such as tachycardia or fibrillation. In some cases, the medical device may sense intrinsic depolarizations of the heart, detect arrhythmia based on the intrinsic depolarizations (or absence thereof), and control delivery of electrical stimulation to the heart if arrhythmia is detected based on the intrinsic depolarizations.
- IMDs may also provide cardiac resynchronization therapy (CRT), which is a form of pacing. CRT involves the delivery of pacing to the left ventricle, or both the left and right ventricles. The timing and location of the delivery of pacing pulses to the ventricle(s) may be selected to improve the coordination and efficiency of ventricular contraction.
- IMDs sense signals and deliver therapeutic stimulation via electrodes. Implantable pacemakers, cardioverters, defibrillators, or pacemaker-cardioverter-defibrillators are typically coupled to one or more subcutaneous electrodes or intracardiac leads that carry electrodes for cardiac sensing and delivery of therapeutic stimulation. The signals sensed via the electrodes may be referred to as a cardiac electrogram (EGM) and may include the depolarizations, repolarizations, and other intrinsic electrical activity of the heart.
- Systems for implanting medical devices may include workstations or other equipment in addition to the medical device itself. In some cases, these other pieces of equipment assist the physician or other technician with placing the intracardiac leads at particular locations on the heart. In some cases, the equipment provides information to the physician about the electrical activity of the heart and the location of the intracardiac lead. The equipment may perform similar functions as the medical device, including delivering electrical stimulation to the heart and sensing the depolarizations of the heart. In some cases, the equipment may include equipment for obtaining an electrocardiogram (ECG) via electrodes on the surface of the patient. In addition, the patient may have a plurality of electrodes on an ECG belt or vest that surrounds the torso of the patient. After the vest has been secured to the torso, a physician can perform a series of tests to evaluate a patient's cardiac response. The evaluation process can include detection of a baseline rhythm in which no electrical stimuli is delivered to cardiac tissue and another rhythm after electrical stimuli is delivered to the cardiac tissue. During the evaluation process, a physician typically needs to review the onset of cardiac depolarization waves in the rhythms. Reliable detection of depolarization waves assists the physician in setting parameters for optimal delivery of CRT. However, most algorithms require threshold detection of the depolarization signal or its derivative. Threshold detection may not reliably and consistently detect onset of cardiac depolarization for all patients and there may be inherent non-physiologic (e.g. noise) variations in thresholded parameters like slopes, amplitudes etc. from one cardiac cycle to another. It is therefore desirable to develop methods and systems of determining onset of cardiac depolarization waves in signals without the use of threshold detection.
-
FIG. 1 is a block diagram illustrating and example system that may determine the onsets and offsets of various heart repolarization and depolarization waves. -
FIG. 2 is a block diagram illustrating an example configuration of a wave detection module. -
FIG. 3 is a graph illustrating an example cardiac electrogram. -
FIG. 4 is a graph illustrating an example cardiac electrogram including R-wave marker information. -
FIG. 5 is a graph illustrating an example cardiac electrogram including R-wave marker information and example windows around each marker. -
FIG. 6 is a graph illustrating an example cardiac electrogram including example determined wave onset points. -
FIG. 7 is a graph illustrating both a cardiac contraction curve and a surface ECG curve with indicators marking the determined onset of depolarization of the heart and the detected timing of local heart mechanical contraction. -
FIG. 8 is a graph illustrating both a cardiac contraction curve at a potential intracardiac lead implant site and a local EGM curve from the same potential implant site with indicators marking the determined onset of local depolarization of the heart and the detected timing of local heart mechanical contraction. -
FIG. 9 is a flow diagram illustrating an example technique for selecting intracardiac lead implant sites. -
FIG. 10 is a flow diagram illustrating an example technique for selecting intracardiac lead implant site. -
FIG. 11A is a conceptual diagram illustrating an example system that determines the onset and offsets of heart depolarization and repolarization waves. -
FIGS. 11B-11C are conceptual diagrams illustrating exemplary systems for measuring torso-surface potentials.FIG. 12 is a conceptual diagram illustrating the implantable medical device (IMD) and leads of the system shown inFIG. 11A in greater detail. -
FIG. 13 is a block diagram of an example implantable medical device that may determine the onset and offset of heart depolarization and repolarization waves. -
FIG. 14 illustrates an example of the time-delay between the delivery of pacing and the onset of depolarization. -
FIG. 15 is a flow diagram illustrating an example technique for detection of onset of heart depolarization waves. -
FIG. 16A is graphically depicts a cardiac ECG signal. -
FIG. 16B graphically depicts a curvature relative to the cardiac ECG signal shown inFIG. 16A . - The techniques and methods described in this disclosure allow a system to determine the onsets and offsets of heart depolarization waves and/or repolarization waves during the process of implanting the implantable medical device (IMD) or post-implant (e.g. periodic medical check-ups after the device has been implanted).
- A computer-implemented method, embodied in
FIG. 15 , is directed to detection of onset of depolarization on far-field electrograms (EGMs), electrocardiograms (ECG)-or ECG-like signals. An ECG-like signal can be for example, a far-field intracardiac electrogram obtained from a device or invasively measured using a mapping wire inside the heart or it can be a leadless ECG generated by an implantable medical device. The method includes determining a baseline rhythm using a plurality of body-surface electrodes. The baseline rhythm includes an atrial marker and a ventricular marker. The atrial marker is associated with an atrial event while a ventricular marker is associated with a ventricular event. Each marker can be displayed to a user on a graphical user interface of a computer such as a programmer. A pre-specified time-window is defined as being between the timing of the atrial marker and timing of the ventricular marker. A low pass filter is then applied to a signal (usually a ECG signal or surrogate of an ECG signal like a far-field EGM, leadless device ECG, etc.) within the window. A rectified slope of the signal within the window is determined. A determination is then made as to whether a time point (t1) is present such that the rectified slope exceeds 10% of a maximum value of the rectified slope. A point of onset of a depolarization complex in the signal is then determined. The point of onset occurs at a largest curvature in the signal within the window from the voltage of the signal of the ventricular marker (Vs)-100 ms to t1, as shown inFIG. 16A . Vs refers to the timing of a ventricular event, for example ventricular sensing, as detected by the sensing circuits within the IMD. A curvature is defined as r=|y″|/(1+|y′|2)(3/2) in which y″ and y′ are the double and single derivatives of a time varying signal y respectively where the time-varying signal is the signal acquired from surface electrodes and/or electrodes associated with an implanted medical device. The first and second derivatives of y can be determined using a variety of known methods. For example, the first derivative, y′, can be determined based on finite difference methods (e.g. difference between successive time samples). The second derivative, y″ can be similarly calculated but instead of using y, different points along y′ curve are used. - In some examples, the diagnostic metrics may be used to optimize or otherwise guide the configuration of therapy, such as cardiac resynchronization therapy (CRT). For CRT, lead placement, pacing electrode configuration, or various atrio-ventricular or interventricular intervals may be configured based on metrics that are determined based on the identified onsets and/or offsets. In some examples, electromechanical delay may be used to configure CRT and, particularly, to select a lead placement, e.g. left-ventricular lead placement, during implantation of a CRT system.
- In general, a heart produces a repetitive electrical signal which causes the heart to mechanically contract, thereby pumping blood throughout the body. Generally, the signal may be detected and displayed as a cardiac electrogram signal. Although the exact representation may differ depending on the placement of leads on or within the body to detect the heart signal, among other factors, a common cardiac electrogram includes several recognizable features. The initial deflections of the signal represent the P-wave and the QRS complex. The P-wave represents the depolarization of the atria and the QRS complex represents the depolarization of the ventricles. The Q-wave of the QRS complex is the initial downward deflection of the signal during the complex. Following the Q-wave is the R-wave, which is an upward deflection of the signal. Finally, the S-wave is another downward deflection. The next portion of the signal represents repolarization of the atria and ventricles. More specifically, what is generally called the T-wave represents the repolarization of the ventricles. There is no specific wave or feature of the signal that represents the repolarization of the atria because the generated signal is small in comparison to the T-wave. Together, the P-wave, the Q, R, and S waves, and the T-wave represent the depolarization and repolarization waves of a heart electrical signal.
- The described techniques may enhance the accuracy of determining the onsets and offsets of the various waves which comprise the repeated cardiac electrogram signal. In particular, knowing more accurately the timing of the onsets and offsets of the waves allows for a more accurate determination of the electrical-electrical delays and the electromechanical delays. For example, the point of onset of ventricular depolarization on surface ECG forms a fiducial element (also simply referred to as “fiducial” or marker) with respect to which local electrical activation or depolarization times and may be measured at different sites in the ventricle. During implant of a heart lead for cardiac resynchronization therapy, the time-interval between this onset point and the time of local activation or depolarization at a candidate implant site within the ventricle may be evaluated and if it exceeds a certain threshold (e.g. 90 ms), that site may be selected for implant.
- Skilled artisans appreciate that a fiducial element may include one or more of a ventricular event (e.g., a ventricular pace, a ventricular sense, etc.), an atrial event 32 a maximum value (e.g., a peak of a QRS complex, a peak of a P-wave, a peak of a Q wave, a peak of a R wave, etc.), a minimum value, a maximum slope value (e.g., a maximum slope of an R-wave, etc.), an amplitude or slope of atrial or ventricular depolarization signal, a crossing of a predefined threshold, etc. The timing of recurring fiducial element, or time when the recurring fiducial occurs, may be used to base the portion of the signal upon. For example, the start of fiducial element may start the time frame or window to store a portion of the signal. A 250 ms portion of the signal starting from a ventricular pace (i.e., the selected fiducial element) may be stored into memory. As such, a first portion may be recorded, or stored, from the start of a ventricular pace for 250 ms during a first a cardiac cycle, and a second portion may be recorded, or stored, from the start of a ventricular pace for 250 ms during a second cardiac cycle that is subsequent to the first cardiac cycle.
-
FIG. 1 is a block diagram illustrating an example configuration of a system for determining the onsets and offsets of heart depolarization and repolarizations waves. In the illustrated example,system 10 includes adevice 60, acardiac electrogram module 70, and amotion sensing module 80.Device 60 may further include aprocessor 72, amemory 74, apeak detection module 76, and awave detection module 78. -
Processor 72 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples,processor 72 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed toprocessor 72 herein may be embodied as software, firmware, hardware or any combination thereof. Generally,processor 72 controlscardiac electrogram module 70,peak detection module 76,wave detection module 78, andmotion sensing module 80 to determine timings of the onsets and offsets of heart depolarization and repolarizations waves. -
Memory 74 includes computer-readable instructions that, when executed byprocessor 72, causessystem 10 andprocessor 72 to perform various functions attributed tosystem 10 andprocessor 72 herein.Memory 74 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media. - Generally,
cardiac electrogram module 70 is configured sense or acquire electrical signals from a patient.Cardiac electrogram module 70 is electrically coupled to one ormore electrodes more electrodes -
Peak detection module 76 may be configured to determine a maximum value of a particular signal. For example,peak detection module 76 may be configured to receive the electrical signal fromcardiac electrogram module 70 and determine the maximum value. In another example, as illustrated inFIG. 2 ,peak detection module 76 may be configured to receive a signal fromwave detection module 78 and determine a maximum value. -
Wave detection module 78 determines the onsets and offsets on the heart depolarization and repolarizations waves.Wave detection module 78 may be configured to receive an electrical signal. For example,wave detection module 78 may be configured to receive an electrical signal sensed bycardiac electrogram module 70.Motion sensing module 80 may detect mechanical motion of a heart, e.g., during contraction of the heart.Motion sensing module 80 may comprise one or more sensors that generate a signal that varies based on cardiac contraction or motion generally, such as one or more accelerometers, pressure sensors, impedance sensors, or flow sensors.Motion sensing module 80 may provide an indication of the timing of motion, e.g., contraction, todevice 60, e.g., toprocessor 72. The detected contraction may be contraction of cardiac tissue at a particular location, e.g., a particular portion of a ventricular wall. - In some examples,
motion sensing module 80 may be configured to image the heart, or electrodes, catheters, wires, or other radio-opaque markers in or on the heart and identify motion associated with contraction based on images of the heart. In some examples,motion sensing module 80 may be configured to direct ultrasound energy toward a patient's heart.Motion sensing module 80 may also be configured to detect any ultrasonic energy deflected back towardmotion sensing module 80 by the patient's heart. In this manner,motion sensing module 80 may capture information about the mechanical motion (i.e. the contracting and relaxing of the ventricles and/or atria) of the heart. Systems and methods for identifying heart mechanical contractions are described in U.S. Pat. No. 7,587,074 to Zarkh et al., which issued on Sep. 8, 2009 and is entitled, “METHOD AND SYSTEM FOR IDENTIFYING OPTIMAL IMAGE WITHIN A SERIES OF IMAGES THAT DEPICT A MOVING ORGAN,” and is incorporated herein by reference in its entirety. -
Processor 72 may determine values of one or more metrics, such as cardiac intervals or cardiac electromechanical delay, based on the timing of onset and/or offset of a wave, as determined bywave detection module 78, and/or the timing of contraction, as determined bymotion sensing module 80. For example,processor 72 may determine QRS width based on an onset and offset of the QRS complex as identified bywave detection module 78. As another example,processor 72 may determine a QT interval based on a QRS onset and T-wave onset identified bywave detection module 78. The processor may also determine the interval between the onset of depolarization on a surface ECG lead and the time of local electrical activation as sensed by a lead or a mapping catheter or guidewire at a site within the heart. Furthermore, as described in greater detail below,processor 72 may determine electromechanical delay based on a QRS onset identified bywave detection module 78 and an indication of the timing of cardiac contraction received frommotion sensing module 80. - Although in
FIG. 1 device 60,module 70, andmodule 80 are depicted as separate, in other examples the modules and device may be combined into fewer separate components. For example, as illustrated inFIG. 13 , all of the functionality ofsystem 10 may be combined into a single device. - Furthermore, although
processor 72,peak detection module 76 andwave detection module 78 are depicted as separate functional modules in the example ofFIG. 1 , their collective functionality may be provided by any number of physical or logical processing elements provided by one or more co-located or networked devices. In one example,peak detection module 76 andwave detection module 78 may be functional modules executed byprocessor 72. Similarly inFIG. 2 , although thevarious modules -
FIG. 2 is a block diagram illustrating an example configuration ofwave detection module 78. In the example ofFIG. 2 ,wave detection module 78 comprises a low-pass filter 90, awindow module 92, aslope module 94, arectifier module 96, a smoothingmodule 98, and athreshold detection module 99. -
Low pass filter 90 may generally be any low-pass filter designed to reduce or eliminate the high frequency components of electrical signals. Some examples of low-pass filters embodied in hardware include capacitive low-pass filters and inductive low-pass filters. Other low-pass filters may be embodied entirely within software. In some embodiments, low-pass filter 90 is embodied as a combination of hardware and software. Low-pass filter 90 may be a first, second, or higher order filter. In some examples, low-pass filter 90 comprises multiple filters placed in a succession in order to create a desired frequency response. In some examples, the low-pass filter 90 is a linear filter with a maximally flat group delay or maximally linear phase response. A constant group delay is a characteristic of phase response of an analog or a digital filter, which helps preserve the shape of the signal in the pass-band. In at least one example, the low-pass filter is a Bessel filter with a cut-off frequency of 15 Hz. -
Window module 92 may generally window received signals. In some examples,window module 92 may receive cardiac electrograms, and in further examples, some of the cardiac electrograms may include a marker or markers indicating one or more points of interest. Some example of points of interest could be the R-wave, the P-wave, or any other wave of the cardiac electrogram. In some examples,peak detection module 76 may detect the locations of R-waves in a cardiac electrogram, according to techniques that are well known in the art, for example using a varying threshold.Peak detection module 76 may then place a marker within the cardiac electrogram identifying the location of the R-wave. In other examples, other modules or devices may detect and mark waves in the cardiac electrogram. In examples where the signal includes at least one marker,window module 92 may window the received electrical signal around the marker. For example,window module 92 may multiply the received electrical signal by zero outside of the area around the marker and by one inside of the area around the marker. In this way,window module 92 may modify the received electrical signal to only contain information in an area around the marker. In some examples,window module 92 may isolate the QRS complex. In some examples,window module 92 may window an area of interest of equal length around the marker, forinstance 150 ms before the marker and 150 ms after the marker. In other examples, the area in front of the marker may be longer or shorter than the area behind the marker. -
Slope module 94 may generally determine the slope of a received electrical signal. Some example techniques for determining a slope thatslope module 94 may use are taking the simple difference between adjacent points on the received electrical signal, or determining the first derivative of the received electrical signal. -
Rectifier module 96 may generally rectify a received electrical signal. For example,rectifier module 96 may half-wave rectify the received electrical signal to produce a resulting signal with information only where the original signal was above zero. In another example,rectifier module 96 may full-wave rectify the received electrical signal to produce a resulting signal where all the negative values of the original signal are now positive. -
Smoothing module 98 may generally smooth a received electrical signal. For example, smoothingmodule 98 may be configured to increase the values of certain points and decrease the values of certain points so as to create a smoother signal. Some example smoothing algorithms include rectangular or un-weighted sliding average smoothing, triangular smoothing, and Savitzky-Golay smoothing. The smoothing algorithms may be implemented through one or more filters. In at least one example, the smoothing filter is 10-order median filter. In another example, the smoothing filter is a n-order median filter where n is an increasing linear function of the sampling frequency used to digitize the electrogram or electrocardiogram signals. -
Threshold detection module 99 may generally be configured to determine a threshold and at what points a received electrical signal crosses a pre-determined threshold. The threshold may be determined based on a maximum value of the signal received from smoothingmodule 98. For example, as illustrated inFIG. 2 ,threshold detection module 99 may be configured to receive, frompeak detection module 76, a maximum value of the signal received from smoothingmodule 98.Threshold detection module 99 may be configured to determine a threshold value based on the received maximum value. For example,threshold detection module 99 may determine the threshold to be ten percent, fifteen percent, twenty percent, or more of the maximum value. Ultimately,threshold detection module 98 may determine the onsets and offsets of heart depolarization and repolarizations waves based on at which points of a received electrical signal cross a threshold. -
FIGS. 3-6 illustrate example cardiac electrogram signals along with various aspects of the present disclosure. For example,FIG. 3 illustrates an examplecardiac electrogram 502 that may be passed to wavedetection module 78.FIG. 4 illustrates acardiac electrogram 502 along withwave markers 504. In the example ofFIG. 4 , wavemarkers 504 are R-wave markers.FIG. 5 also depicts an examplecardiac electrogram 502 and R-wave markers 504.FIG. 5 also depictsexample windows 506 that wavedetection module 78, e.g. throughwindow module 92, may generate about thewave markers 504. In the example ofFIG. 5 ,windows 506 are configured to generally include the QRS complexes and isolate the QRS complexes from the whole cardiac electrogram, e.g. exclude other waves such as the P-wave and T-wave. In other examples, thewindows 506 may be configured to generally include P or T-waves and isolate those waves from the whole cardiac electrogram.FIG. 6 further illustrates an examplecardiac electrogram 502.FIG. 6 also illustrates the points that wavedetection module 78 has determined are the onset of the waves (more specifically, in the example illustrated inFIG. 6 , the onset of the QRS waves). -
FIGS. 7 and 8 illustrate example cardiac electrograms combined with example heart mechanical contraction information. For example,FIG. 7 depicts an examplesurface ECG signal 702 along with acardiac contraction curve 704.Cardiac contraction curve 704 illustrates the contraction of a local point on the heart with respect to time. The cardiac contraction curve may be a signal generated by any of the sensors discussed above, for example accelerometers, pressure sensors, impedance sensors, or flow sensors associated withmotion sensing module 80. In other examples, the cardiac contraction curve may be generated by the techniques described in the U.S. Pat. No. 7,587,074 to Zarkh et al., which issued on Sep. 8, 2009 and is entitled, “METHOD AND SYSTEM FOR IDENTIFYING OPTIMAL IMAGE WITHIN A SERIES OF IMAGES THAT DEPICT A MOVING ORGAN,” incorporated herein. In still other examples, the cardiac contraction curve may be generated by sensors within the tip of an intracardiac electrode. For example, the tip of a cardiac electrode may contain one or more motion sensors which generates a signal as the tip of the electrode moves in relation to the region of the heart in which it is implanted. - Also depicted in
FIG. 7 are the timing of the detected onset of depolarization of the heart from the surface ECG 706 and the timing of the localcardiac contraction 708. The delay between the onset of depolarization 706 from the surface ECG and the timing of localcardiac contraction 708 may be described as the globalelectromechanical delay 710. As will be described in greater detail inFIGS. 9-10 , measuring the globalelectromechanical delay 710 delay at various locations on the heart may help physicians to select potential intracardiac lead implant sites. -
FIG. 8 depicts an example unipolarcardiac electrogram signal 752 from an electrode at a localized position on or within a heart, along with acardiac contraction curve 754 from the same localized position on or within the heart.FIG. 8 also depicts the timing of the detected onset of depolarization of the heart at thelocalized position 756 and the timing of the localcardiac contraction 758. In contrast toFIG. 7 ,FIG. 8 displays the difference in timing between the local depolarization of theheart 756 and the timing of the localcardiac contraction 758 as the localelectromechanical delay 760 or localelectromechanical latency 760. The localelectromechanical delay 760 differs from the globalelectromechanical delay 710 in that localelectromechanical delay 760 measures the differences in timings both at the localized heart tissue and the globalelectromechanical delay 710 measures the difference in timings between the depolarization 706 detected at the surface ECG and the localmechanical contraction 708. -
FIG. 9 is a flow diagram describing an example method for selecting an implant site for an intracardiac lead. In the example method, a system, such assystem 10 ofFIG. 1 , may determine the intrinsic global electromechanical delay at a plurality of potential intracardiac lead implant sites. To determine the intrinsic global electromechanical delay, a system may determine the timing of a detected onset of depolarization from a surface ECG and a timing of cardiac contraction at various locations on the heart during an intrinsic heart rhythm. The difference between the timings is the global electromechanical delay (800). Then, in the example technique, a system, e.g.,processor 72, or a user of the system, may select candidate intracardiac lead implant sites as sites that have a global electromechanical delay above a certain threshold (802). Finding particular candidate sites with a long global electromechanical delay may indicate that the particular location of the heart contracts late and may be the reason for dyssynchrony of cardiac wall motion. Selecting an implant site to provide pacing on or near that site may enhance the effectiveness of the electrical pacing therapy to restore cardiac synchrony. - In the example technique,
processor 72 may then determine the local electromechanical delay of the selected candidate implant sites during an intrinsic heart rhythm (804). To determine the local electromechanical delay,processor 72 may determine the timing of a detected onset of depolarization from an electrogram taken at the potential implant site and a timing of the local cardiac contraction at the potential implant sites. The local electromechanical delay is the difference between the determined timings. Then, in the example technique,processor 72 may automatically select a subset of potential implant sites as sites that have a local electromechanical delay less than a threshold (806). In other examples, a user may manually select the potential implants based on information fromprocessor 72. Candidate implant sites that have a long local electromechanical delay may indicate a region of scarred or non-viable or otherwise non-conductive tissue. Implanting an intracardiac lead at those locations may reduce the effectiveness of the electrical stimulation therapy. -
Processor 72 may then deliver electrical pacing stimulus to the heart at the potential implant sites (808).Processor 72 may measure various metrics such as global or local electromechanical delay during pacing at each potential implant site. In the example technique,processor 72 may then automatically select one or more implant sites based on the reduction of a metric during pacing compared to the intrinsic baseline. In other examples, a user may select one or more implant sites based on information fromprocessor 72. For example,processor 72, or a user, may select one or more implant sites based on the reduction of local electromechanical, global electromechanical delay, or cardiac dyssynchrony, which is a measure of the distribution and dispersion (e.g. range, standard deviation, etc.) of global or local electromechanical delays at various cardiac sites. In other example techniques,processor 72 or a user may select other parameters based on the global and/or local electromechanical delay. For example,processor 72 may also vary parameters of the pacing, such as A-V delay, V-V delay, and pacing electrode configuration, and select a particular pacing electrode configuration or pacing intervals for cardiac resynchronization therapy based on the metric. In other examples, a user may ultimately select the pacing electrode configuration or pacing intervals based on the metric. -
FIG. 10 is flow diagram illustrating another example technique for selecting an implant site for an intracardiac lead. In the example technique, a system, such assystem 10, may determine a global electromechanical delay at a potential implant site during an intrinsic heart rhythm (850). In the example technique, a system may then determine local electromechanical delay at the same potential implant site during an intrinsic heart rhythm (852). A system may then determine a baseline electromechanical dyssynchrony index for an intrinsic heart rhythm (854). A system may determine the baseline electromechanical dyssynchrony index by comparing the differences between the global and local electromechanical delays during the intrinsic heart rhythm. - In the example technique, a system may then determine a global electromechanical delay at the same potential implant site during the delivery of electrical pacing therapy (856). In the example technique, a system may then determine local electromechanical delay at the same potential implant site during the delivery of electrical pacing therapy (858). A system may then determine an electromechanical dyssynchrony index during pacing therapy (860).
- In the example technique, a system may then determine the percentage change between the baseline electromechanical dyssynchrony index and the electromechanical dyssynchrony index determined during pacing therapy (862). A system may then determine if there was a reduction from the baseline dyssynchrony index at the tested potential implant site above a threshold percentage (864). If the system determines that the performance of the pacing at the potential implant site did produce a reduction in the baseline electromechanical dyssynchrony index above a threshold percentage (YES of 864), the system may select that implant site (866) for intracardiac lead implantation. In some examples, a processor of the system, such as
processor 72, may automatically select the implant site according to the described techniques. In other examples, a user, based on information from a processor may manually select the implant site according to the described techniques. If the system determines that pacing at the potential site did not reduce the baseline electromechanical dyssynchrony index by a threshold percentage amount (NO of 864), the system may check to see if there are other potential lead implant sites to check (868). If there are still other implant sites to check (YES of 868), in the example technique, a system may change the potential lead implant site (870) and return to step 856. If there are no more potential lead implant sites to check (NO of 868), a system may select the implant site with the greatest reduction in the baseline electromechanical dyssynchrony index as the preferred intracardiac lead implant site. - In another example, the system may detect the time-interval from delivery of pace at a localized region within the heart to the onset of depolarization on a surface ECG lead, with the pace delivered at maximum pacing voltage (˜6V to ensure that maximum energy is delivered during pacing) and at a short atrio-ventricular (A-V) interval (≦60 ms). If this time interval exceeds a certain threshold, then the system will indicate that particular area is not a suitable site for implanting the pacing lead. This is because a long time delay between delivery of local pace (at maximum energy) and onset of global depolarization on surface ECG indicates that the substrate of that area in the heart may be non-viable or otherwise not be a suitable site for implanting the pacing lead, e.g., comprised of scar tissue.
FIG. 14 illustrates an example of the time-delay between the delivery of pacing and the onset of depolarization.FIG. 14 illustrates anexample ECG signal 990.Arrow 992 points to the point in time when a patient received pacing at a localized region of the heart.Arrow 994 points to the determined point in time of the onset of the depolarization wave. The onset of the depolarization wave may be found, for example, according the techniques described in this disclosure.Time period 996 is the difference in time between the beginning of pacing and the onset of the depolarization wave at a localized region of the heart. Thetime period 996 may also be termed the local electrical-electrical delay. -
FIGS. 11-13 are conceptual diagrams illustrating anexample system 910 that determines the onset and offset points of heart depolarization and repolarization waves ofpatient 914 according to the techniques described herein. As with the previously described system, in one example,system 910 may detect the onset and offset points of heart depolarization and repolarization waves in order to select a preferred location for implanting an intracardiac lead. In other examples,system 910 may detect the onset and offset points of heart depolarization and repolarization waves in order to select other parameters based on the electromechanical delay. For example, the system may select a particular pacing electrode configuration or pacing intervals for cardiac resynchronization therapy. In another example, with multipolar leads offering choices of more than one pacing electrode (cathode) in the ventricle, the system/device may automatically pace from each of the pacing electrodes at maximum pacing voltage and at a nominal atrio-ventricular delay (˜100 ms) and measure onsets and offsets of the resulting depolarization waveforms on a far-field electrogram or on a leadless ECG or on a surface ECG lead, and choose the pacing electrode which produces the minimum difference between the offset of the local electrogram and the corresponding far-field onset, for delivery of cardiac resynchronization therapy. Alternatively, the pacing electrode which produces the narrowest far-field electrogram or surface ECG signal calculated as the difference between the offset and onset could be chosen. As illustrated in example diagramFIG. 11A , asystem 910 includes implantable medical device (IMD) 916, which is connected to leads 918, 920, and 922, and communicatively coupled to aprogrammer 924.IMD 916 senses electrical signals attendant to the depolarization and repolarization ofheart 912, e.g., a cardiac EGM, via electrodes on one or more ofleads IMD 916.IMD 916 also delivers therapy in the form of electrical signals toheart 912 via electrodes located on one or more leads 918, 920, and 922 or a housing ofIMD 916, such pacing, cardioversion and/or defibrillation pulses.IMD 916 may include or be coupled to various sensors, such as one or more accelerometers, for detecting other physiological parameters ofpatient 914, such as activity or posture. - In some examples,
programmer 924 takes the form of a handheld computing device, computer workstation, or networked computing device that includes a user interface for presenting information to and receiving input from a user. A user, such as a physician, technician, surgeon, electrophysiologist, or other clinician, may interact withprogrammer 924 to communicate withIMD 916. For example, the user may interact withprogrammer 924 to retrieve physiological or diagnostic information fromIMD 916. A user may also interact withprogrammer 924 to programIMD 916, e.g., select values for operational parameters of the IMD. -
IMD 916 andprogrammer 924 may communicate via wireless communication using any techniques known in the art. Examples of communication techniques may include, for example, low frequency or radiofrequency (RF) telemetry, but other techniques are also contemplated. In some examples,programmer 924 may include a programming head that may be placed proximate to the patient's body near theIMD 916 implant site in order to improve the quality or security of communication betweenIMD 916 andprogrammer 924. In other examples,programmer 924 may be located remotely fromIMD 916, and communicate withIMD 916 via a network. - The techniques for identifying onsets and/or offsets of cardiac electrogram waves may be performed by
IMD 916, e.g., by a processor ofIMD 916, based on one or more cardiac electrograms sensed by the IMD. In other examples, as described previously, some or all of the functions ascribed toIMD 916 or a processor thereof may be performed by one or more other devices, such as programmer 294 or a workstation (not shown), or a processor thereof. For example,programmer 924 may process EGM signals received fromIMD 916 and/or cardiac mechanical contraction information to according to the techniques described herein. Furthermore, although described herein with respect to an IMD, in other examples, the techniques described herein may be performed by or implemented in an external medical device, which may be coupled to a patient via percutaneous or transcutaneous leads. -
FIGS. 11B and 11C are conceptual diagrams illustrating example systems for measuring body-surface potentials and, more particularly, torso-surface potentials. In one example illustrated inFIG. 11B ,sensing device 1000A, comprising a set ofelectrodes 1002A-F (generically “electrodes 1002”) andstrap 1008, is wrapped around the torso ofpatient 914 such that the electrodes surroundheart 912. As illustrated inFIG. 11B , electrodes 1002 may be positioned around the circumference ofpatient 914, including the posterior, lateral, and anterior surfaces of the torso ofpatient 914. In other examples, electrodes 1002 may be positioned on any one or more of the posterior, lateral, and anterior surfaces of the torso. Electrodes 1002 may be electrically connected to a processing unit such asdevice 60 viawired connection 1004. Some configurations may use a wireless connection to transmit the signals sensed by electrodes 1002 todevice 60, e.g., as channels of data. - Although in the example of
FIG. 11B sensing device 1000A comprisesstrap 1008, in other examples any of a variety of mechanisms, e.g., tape or adhesives, may be employed to aid in the spacing and placement of electrodes 1002. In some examples,strap 1008 may comprise an elastic band, strip of tape, or cloth. In some examples, electrodes 1002 may be placed individually on the torso ofpatient 914. - Electrodes 1002 may surround
heart 912 ofpatient 914 and record the electrical signals associated with the depolarization and repolarization ofheart 912 after the signals have propagated through the torso ofpatient 914. Each of electrodes 1002 may be used in a unipolar configuration to sense the torso-surface potentials that reflect the cardiac signals.Device 60 may also be coupled to a return or indifferent electrode (not shown) which may be used in combination with each of electrodes 1002 for unipolar sensing. In some examples, there may be 12 to 16 electrodes 1002 spatially distributed around the torso ofpatient 914. Other configurations may have more or fewer electrodes 1002. - Processing
unit 60 may record and analyze the torso-surface potential signals sensed by electrodes 1002. As described herein,device 60 may be configured to provide an output to a user. The user may make a diagnosis, prescribe CRT, position therapy devices, e.g., leads, or adjust or select treatment parameters based on the indicated output. - In some examples, the analysis of the torso-surface potential signals by
device 60 may take into consideration the location of electrodes 1002 on the surface of the torso ofpatient 914. In such examples,device 60 may be communicatively coupled to anmotion sensing module 80 such as a programmer, which may provide an image that allowsdevice 60 to determine coordinate locations of each of electrodes 1002 on the surface ofpatient 914. Electrodes 1002 may be visible, or made transparent through the inclusion or removal of certain materials or elements, in the image provided bymotion sensing module 80. -
FIG. 11C illustrates an example configuration of a system that may be used to evaluate cardiac response inheart 912 ofpatient 914. The system comprises a sensing device 10008, which may comprisevest 1006 and electrodes 1002 A-ZZ (generically “electrodes 1002”), adevice 60, and imaging system 501.Device 60 and imaging system 501 may perform substantially as described above with respect toFIG. 11A . As illustrated inFIG. 11C , electrodes 1002 are distributed over the torso ofpatient 914, including the anterior, lateral, and posterior surfaces of the torso ofpatient 914. -
Sensing device 1000B may comprise afabric vest 1006 with electrodes 1002 attached to the fabric.Sensing device 1000B may maintain the position and spacing of electrodes 1002 on the torso ofpatient 914.Sensing device 1000B may be marked to assist in determining the location of electrodes 1002 on the surface of the torso ofpatient 914. In some examples, there may be 150 to 256 electrodes 1002 distributed around the torso ofpatient 914 usingsensing device 1000B, though other configurations may have more or fewer electrodes 1002. - The ECG data is mapped to a generic, graphical model of a patient's torso and/or heart and a graphical display is produced on a graphical user interface without taking an actual image, such as an MRI or CT image, from the patient. The resolution of the ECG data mapped to a graphical anatomical model depends on the number and spacing of surface electrodes 1002 used. In some examples, there may be 12 to 16 electrodes spatially distributed around the torso of
patient 914. Other configurations may have more or fewer electrodes. In one embodiment, a minimum number of electrodes includes twelve electrodes arranged in two rows extending along the posterior torso and twelve electrodes arranged in two rows extending along the anterior torso for a total of twenty-four electrodes, which may be equally distributed circumferentially around the torso. -
FIG. 12 is a conceptualdiagram illustrating IMD 916 and leads 918, 920, and 922 ofsystem 910 in greater detail. In the illustrated example,bipolar electrodes lead 918. In addition,bipolar electrodes lead 920, andbipolar electrodes lead 922. - In the illustrated example,
electrodes electrodes Leads elongated electrodes electrodes lead IMD 916. - In some examples,
IMD 916 includes one or more housing electrodes, such ashousing electrode 904 illustrated inFIG. 12 , which may be formed integrally with an outer surface of hermetically-sealedhousing 908 ofIMD 916 or otherwise coupled tohousing 908. In some examples,housing electrode 904 is defined by an uninsulated portion of an outward facing portion ofhousing 908 ofIMD 916. Other division between insulated and uninsulated portions ofhousing 908 may be employed to define two or more housing electrodes. In some examples, a housing electrode comprises substantially all ofhousing 908. - As described in further detail with reference to
FIG. 13 ,housing 908 encloses a signal generator that generates therapeutic stimulation, such as cardiac pacing, cardioversion and defibrillation pulses, as well as a sensing module for sensing electrical signals attendant to the depolarization and repolarization ofheart 912.Housing 908 may also enclose a wave detection module that detects the onsets and offsets of heart depolarization and repolarization waves. The wave detection module may be enclosed withinhousing 908. Alternatively, the wave detection module may housed in a remote piece of equipment, such asprogrammer 924 or a workstation (not shown) and communicate with theIMD 916 through wireless communication. -
IMD 916 senses electrical signals attendant to the depolarization and repolarization ofheart 912 viaelectrodes IMD 916 may sense such electrical signals via any bipolar combination ofelectrodes electrodes housing electrode 904. - In some examples,
IMD 916 delivers pacing pulses via bipolar combinations ofelectrodes heart 912. In some examples, IMD 16 delivers pacing pulses via any ofelectrodes housing electrode 904 in a unipolar configuration. Furthermore,IMD 916 may deliver cardioversion or defibrillation pulses to heart 12 via any combination ofelongated electrodes housing electrode 904. - The illustrated numbers and configurations of
leads system 910 may include an additional lead or lead segment having one or more electrodes positioned at different locations in the cardiovascular system for sensing and/or delivering therapy topatient 914. For example, instead of or in addition to intracardiac leads 918, 920 and 922,system 910 may include one or more epicardial or subcutaneous leads not positioned within the heart. In some examples, the subcutaneous leads may sense a subcutaneous cardiac electrogram, for example the far-field electrogram between the SVC coil and the can. The subcutaneous cardiac electrogram may substitute for the surface ECG in determining the global electromechanical delay. -
FIG. 13 is a block diagram illustrating an example configuration ofIMD 916. In the illustrated example,IMD 916 includes aprocessor 970,memory 972,signal generator 974,sensing module 976,telemetry module 978,motion sensing module 980,wave detection module 982 andpeak detection module 984.Memory 972 includes computer-readable instructions that, when executed byprocessor 970, causesIMD 916 andprocessor 970 to perform various functions attributed toIMD 916 andprocessor 970 herein.Memory 972 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as a random access memory (RAM), read-only memory (ROM), non-volatile RAM (NVRAM), electrically-erasable programmable ROM (EEPROM), flash memory, or any other digital or analog media. -
Processor 970 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or analog logic circuitry. In some examples,processor 970 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed toprocessor 970 herein may be embodied as software, firmware, hardware or any combination thereof. Generally,processor 970 controls signalgenerator 974 to deliver stimulation therapy toheart 912 ofpatient 914 according to a selected one or more of therapy programs or parameters, which may be stored inmemory 972. As an example,processor 970 may controlsignal generator 974 to deliver electrical pulses with the amplitudes, pulse widths, frequency, or electrode polarities specified by the selected one or more therapy programs. -
Signal generator 974 is configured to generate and deliver electrical stimulation therapy topatient 912. As shown inFIG. 13 ,signal generator 974 is electrically coupled toelectrodes housing electrode 904, withinhousing 908. For example,signal generator 974 may deliver pacing, defibrillation or cardioversion pulses toheart 912 via at least two ofelectrodes signal generator 974 delivers stimulation in the form of signals other than pulses, such as sine waves, square waves, or other substantially continuous time signals. -
Signal generator 974 may include a switch module (not shown) andprocessor 970 may use the switch module to select, e.g., via a data/address bus, which of the available electrodes are used to deliver the electrical stimulation. The switch module may include a switch array, switch matrix, multiplexer, or any other type of switching device suitable to selectively couple stimulation energy to selected electrodes.Electrical sensing module 976 monitors electrical cardiac signals from any combination ofelectrodes Sensing module 976 may also include a switch module whichprocessor 970 controls to select which of the available electrodes are used to sense the heart activity, depending upon which electrode combination is used in the current sensing configuration. -
Sensing module 976 may include one or more detection channels, each of which may comprise an amplifier. The detection channels may be used to sense the cardiac signals. Some detection channels may detect events, such as R-waves or P-waves, and provide indications, such as wave markers, of the occurrences of such events toprocessor 970. One or more other detection channels may provide the signals to an analog-to-digital converter, for conversion into a digital signal for processing or analysis byprocessor 970. - For example,
sensing module 976 may comprise one or more narrow band channels, each of which may include a narrow band filtered sense-amplifier that compares the detected signal to a threshold. If the filtered and amplified signal is greater than the threshold, the narrow band channel indicates that a certain electrical cardiac event, e.g., depolarization, has occurred.Processor 970 then uses that detection in measuring frequencies of the sensed events. - In one example, at least one narrow band channel may include an R-wave or P-wave amplifier. In some examples, the R-wave and P-wave amplifiers may take the form of an automatic gain controlled amplifier that provides an adjustable sensing threshold as a function of the measured R-wave or P-wave amplitude. Examples of R-wave and P-wave amplifiers are described in U.S. Pat. No. 5,117,824 to Keimel et al., which issued on Jun. 2, 1992 and is entitled, “APPARATUS FOR MONITORING ELECTRICAL PHYSIOLOGIC SIGNALS,” and is incorporated herein by reference in its entirety.
- In some examples,
sensing module 976 includes a wide band channel which may comprise an amplifier with a relatively wider pass band than the narrow band channels. Signals from the electrodes that are selected for coupling to this wide-band amplifier may be converted to multi-bit digital signals by an analog-to-digital converter (ADC) provided by, for example,sensing module 976 orprocessor 970.Processor 970 may analyze the digitized versions of signals from the wide band channel.Processor 970 may employ digital signal analysis techniques to characterize the digitized signals from the wide band channel to, for example, detect and classify the patient's heart rhythm. -
Processor 970 may detect and classify the patient's heart rhythm based on the cardiac electrical signals sensed by sensingmodule 976 employing any of the numerous signal processing methodologies known in the art. For example,processor 970 may maintain escape interval counters that may be reset upon sensing of R-waves by sensingmodule 976. The value of the count present in the escape interval counters when reset by sensed depolarizations may be used byprocessor 970 to measure the durations of R-R intervals, which are measurements that may be stored inmemory 972.Processor 970 may use the count in the interval counters to detect a tachyarrhythmia, such as ventricular fibrillation or ventricular tachycardia. A portion ofmemory 972 may be configured as a plurality of recirculating buffers, capable of holding series of measured intervals, which may be analyzed byprocessor 970 to determine whether the patient'sheart 912 is presently exhibiting atrial or ventricular tachyarrhythmia. - In some examples,
processor 970 may determine that tachyarrhythmia has occurred by identification of shortened R-R interval lengths. Generally,processor 970 detects tachycardia when the interval length falls below 360 milliseconds (ms) and fibrillation when the interval length falls below 320 ms. These interval lengths are merely examples, and a user may define the interval lengths as desired, which may then be stored withinmemory 972. This interval length may need to be detected for a certain number of consecutive cycles, for a certain percentage of cycles within a running window, or a running average for a certain number of cardiac cycles, as examples. - In some examples, an arrhythmia detection method may include any suitable tachyarrhythmia detection algorithms. In one example,
processor 970 may utilize all or a subset of the rule-based detection methods described in U.S. Pat. No. 5,545,186 to Olson et al., entitled, “PRIORITIZED RULE BASED METHOD AND APPARATUS FOR DIAGNOSIS AND TREATMENT OF ARRHYTHMIAS,” which issued on Aug. 13, 1996, or in U.S. Pat. No. 5,755,736 to Gillberg et al., entitled, “PRIORITIZED RULE BASED METHOD AND APPARATUS FOR DIAGNOSIS AND TREATMENT OF ARRHYTHMIAS,” which issued on May 26, 1998. U.S. Pat. No. 5,545,186 to Olson et al. U.S. Pat. No. 5,755,736 to Gillberg et al. is incorporated herein by reference in their entireties. However, other arrhythmia detection methodologies may also be employed byprocessor 970 in other examples. For example, EGM morphology may be considered in addition to or instead of interval length for detecting tachyarrhythmias. - Generally,
processor 970 detects a treatable tachyarrhythmia, such as VF, based on the EGM, e.g., the R-R intervals and/or morphology of the EGM, and selects a therapy to deliver to terminate the tachyarrhythmia, such as a defibrillation pulse of a specified magnitude. The detection of the tachyarrhythmia may include a number of phases or steps prior to delivery of the therapy, such as first phase, sometimes referred to as detection, in which a number of consecutive or proximate R-R intervals satisfies a first number of intervals to detect (NID) criterion, a second phase, sometimes referred to as confirmation, in which a number of consecutive or proximate R-R intervals satisfies a second, more restrictive NID criterion. Tachyarrhythmia detection may also include confirmation based on EGM morphology or other sensors subsequent to or during the second phase. - In the illustrated example,
IMD 916 also includespeak detection module 980,wave detection module 982, andmotion sensing module 984.Peak detection module 980 andwave detection module 982 may be configured and provide the functionality ascribed to peakdetection module 76 andwave detection module 78 herein.Peak detection module 980 may be configured to determine a maximum value of a particular signal. For example,peak detection module 980 may be configured to receive an electrical signal fromwave detection module 982 orprocessor 970 and determine a maximum value of the received signal.Peak detection module 980 may, in some examples, comprise a narrow-band channel ofsensing module 976 that is configured to detect R-waves, P-waves, or T-waves in cardiac electrogram signals, e.g., using an amplifier with automatically adjusting threshold. - Generally,
wave detection module 982 determines the onsets and offsets on the heart depolarization and repolarizations waves.Wave detection module 982 may be similar to the wave detection module described previously, e.g.wave detection module 78, and more accurately described inFIG. 2 . For example, wave detection module may include a low-pass filter, a window module, a slope module, a rectifier module, a smoothing module, and a threshold detection module.Wave detection module 982 may perform substantially similar to the wave detection module described previously in this application. -
Peak detection module 980 andwave detection module 982 may receive a cardiac electrogram from sensingmodule 976, e.g., from a wide-band channel of the sensing module. In some examples, the cardiac electrogram may be a far-field cardiac electrogram, e.g., between superior vena cava coil 766 andhousing electrode 904. A far-field cardiac electrogram may be used in the manner described herein with respect to a surface ECG, e.g., to determine a global electromechanical delay. In some examples, the cardiac electrogram may be a unipolar cardiac electrogram between housing electrode 906 and any ofelectrodes sensing module 976, e.g., via a wide-band channel of the sensing module, and may be used in the manner described herein with respect to local cardiac electrogram signals, e.g., to determine local electromechanical delays. -
Motion sensing module 984 may sense the mechanical contraction of the heart, e.g., at one or more cardiac sites.Motion sensing module 984 may be electrically coupled to one or more sensors that generate a signal that varies based on cardiac contraction or motion generally, such as one or more accelerometers, pressure sensors, impedance sensors, or flow sensors. The detected contraction may be contraction of cardiac tissue at a particular location, e.g., a particular portion of a ventricular wall. - Although
processor 970 andwave detection module 982 are illustrated as separate modules inFIG. 13 ,processor 970 andwave detection module 982 may be incorporated in a single processing unit.Wave detection module 982, and any of its components, may be a component of or module executed byprocessor 970. -
Telemetry module 978 includes any suitable hardware, firmware, software or any combination thereof for communicating with another device, such as programmer 924 (FIG. 11 ). In some examples,programmer 924 may include a programming head that is placed proximate to the patient's body near theIMD 916 implant site, and inother examples programmer 924 andIMD 916 may be configured to communicate using a distance telemetry algorithm and circuitry that does not require the use of a programming head and does not require user intervention to maintain a communication link. Under the control ofprocessor 970,telemetry module 978 may receive downlink telemetry from and send uplink telemetry toprogrammer 924 with the aid of an antenna, which may be internal and/or external. In some examples,processor 970 may transmit cardiac signals produced by sensingmodule 976 and/or signals generated byheart sound sensor 982 toprogrammer 924.Processor 970 may also generate and store marker codes indicative of different cardiac events thatsensing module 976 orheart sound analyzer 980 detects, and transmit the marker codes toprogrammer 924. An example IMD with marker-channel capability is described in U.S. Pat. No. 4,374,382 to Markowitz, entitled, “MARKER CHANNEL TELEMETRY SYSTEM FOR A MEDICAL DEVICE,” which issued on Feb. 15, 1983 and is incorporated herein by reference in its entirety. Information whichprocessor 970 may transmit toprogrammer 924 viatelemetry module 978 may also include indications of treatable rhythms, and indications of non-treatable rhythms in which the EGM based indication indicated that the rhythm was treatable and the heart sound based indication indicated that the rhythm was non-treatable. Such information may be included as part of a marker channel with an EGM. - The flow diagram depicted in
FIG. 15 discloses a computer-implementedmethod 1100 that determines onsets and/or offsets of cardiac depolarization waves without using a threshold-based detection algorithm. Detection of onset of a depolarization wave is desirable since CRT may be optimized. By way of illustration, CRT data such as q-LV times and activation times are automatically determined, which is useful when implanting a left ventricular lead. For example, a programmer can be set to automatically check if the local q-LV time is greater than a predetermined value (e.g. 90-100 ms). If the local q-LV time is greater than the predetermined value, the local q-LV time is displayed on the graphical user interface of the programmer to the user (e.g. physician or implanter) so that the left ventricular lead can be properly positioned. Generally, sites with q-LV>90-100 ms sites are preferable for LV lead implantation as opposed to sites with a shorter q-LV. - Implementation of
method 1100 requires a plurality of body-surface electrodes such as an ECG belt or vest be placed around the torso of the patient. An exemplary ECG belt or vest is described in U.S. patent application Ser. No. 13/462,404, filed May 2, 2012, entitled “Assessing Intra-Cardiac Activation Patterns And Electrical Dyssynchrony” and assigned to the assignee of the present invention, the disclosure of which is incorporated by reference in its entirety herein. After the vest or belt is secured around the patient's torso, the programmer is activated. Exemplary programmers that can be used to acquire signals from implanted and surface electrodes includes the Medtronic Carelink Programmer Model 2090 and the Model 2290 Analyzer or the CARELINK ENCORE™. Medtronic Vitatron Reference Manual CARELINK ENCORE™ (2013) available at http://manuals.medtronic.com/manuals/main/as/en/manual, the disclosure of which is incorporated by reference in its entirety. - Far-field EGMs, ECG, or ECG-like signals are acquired from an electrode that is the greatest distance away from the pacing electrode. If an IMD is implanted, electrodes that can produce far field signals include superior vena cava (SVC) electrode-pulse generator housing (also referred to as a “can”), right ventricle (RV) coil-can etc.).
-
Method 1100 starts atoperation 1102 in which a baseline rhythm is acquired from a plurality of body-surface electrodes and then stored into memory. The baseline rhythm includes fiducials such as an atrial wave marker and a ventricular wave marker. The atrial wave marker is associated with an atrial event (e.g., an atrial sense, etc.), while a ventricular wave marker is associated with a ventricular event (e.g., a ventricular sense, etc.). Each marker can be displayed to a user on a graphical user interface of a computer such as a programmer. - At
block 1104, a pre-specified window is set. The pre-specified window can be defined as extending from the atrial marker to the ventricular marker, an example of which is shown along the ECG signal inFIG. 16A . The y-axis is in millivolts (mv) and the x-axis is time in milliseconds (ms) forFIG. 16A . - A low pass filter is then applied at
block 1106 to the ECG signal within the pre-specified window. The low-pass filter can be a Bessel filter with a cut-off frequency of 15 Hz, 20 Hz or a frequency value between 15 Hz and 20 Hz. The signal(s) acquired from the plurality of surface electrodes and/or the electrodes associated with the implantable medical device is passed through the low pass filter, which causes the removal of any spurious high-frequency artifacts or components from the far-field ECG-like signal. - A rectified slope of the signal within the window is determined at
block 1108 usingmodule 96 depicted inFIG. 2 . Rectification of a signal can be performed by any known method. Atblock 1110, a time point (t1) (shown inFIG. 16A ) is determined such that the rectified slope exceeds 10% of a maximum value of the rectified slope. A point of onset of a depolarization complex in the signal is determined atblock 1112. The point of onset of the depolarization signal requires the radii of the curvature of the signal within the pre-specified window to be determined, as shown inFIG. 16B . The radii is plotted along a y-axis in curvature (curvature-mV) units and a x-axis in time of milliseconds. The radius of the curvature equation used to plotFIG. 16B is defined as r=|y″|/(1+|y′|2)(3/2) in which y″ and y′ are the double and single derivatives of respectively. y is the signal acquired from surface electrodes and/or electrodes associated with an implanted medical device. The first and second derivatives of the signal, represented by y=f(t), can be determined using a variety of known methods. Firmware or other computer instructions, stored in memory, can determine the derivatives of y(t). For example, the first derivative, y′, can be determined by repeatedly calculating the slope between two different points along the signal. The second derivative, y″ can be similarly calculated but instead of using y(t), different points along y′ curve are used. In another embodiment a simplified expression tracking the curvature may be used like r≈|y″|/(1+|y′|2) which makes it easier from the computational standpoint, eliminating the need of computing square roots. The simplified curvature equation r≈|y″|/(1+|y′|2), (the radii shown by the dashed line inFIG. 16B ), can also be used to compute an index that tracks the curvature. - In particular, the algorithm searches radii along points in the curve in order to locate the greatest curvature (shown in
FIGS. 16A-16B ) within a window of pre-specified width and ending on the maximum peak, or minimum valley. The radius of the curvature is solely determined for the signal within the pre-specified window. In one or more other embodiments involving biphasic signals, the algorithm is configured to search for the greatest curvature within a window of pre-specified width and ending on the maximum peak, or minimum valley, whichever is greater in magnitude between the maximum and minimum peaks. - The onset of depolarization is identified by the point associated with the maximum curvature within the search window, as shown in
FIGS. 16A-16B . In particular, the point of onset occurs at a largest curvature in the signal within the window from Vs-100 ms to t1. The largest curvature in the signal occurs at the highest value at points in which a sharp deflection exists which is indicative of the onset of depolarization on an ECG-like signal. After determining the onset of depolarization, the user can make appropriate adjustments to the implantable medical device in order to optimize CRT. While the techniques described inFIG. 15 have been applied to the onset of depolarization, the same principles can be applied to detection of the onset of repolarization signals such as T waves. As applied to repolarization signals, useful data can be obtained for adjusting Q-T intervals for CRT. - The stable and reliable algorithm, described in
method 1100, detects QRS onset with minimum inputs or manipulation from the user. Additionally, the algorithm may be incorporated within an IMD (e.g. CRT device) for marking the onset of QRS waves on leadless ECG or ECG or other far-field ECG-like signals. By incorporating the algorithm into the IMD, measurements of electrical activation times are automated with respect to the onset of QRS waves and/or T waves. - The techniques described in this disclosure, including those attributed to IMD
wave detection module 80, programmer 24, or various constituent components, may be implemented, at least in part, in hardware, software, firmware or any combination thereof. For example, various aspects of the techniques may be implemented within one or more processors, including one or more microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components, embodied in programmers, such as physician or patient programmers, stimulators, image processing devices or other devices. The term “processor” or “processing circuitry” may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry. - Such hardware, software, firmware may be implemented within the same device or within separate devices to support the various operations and functions described in this disclosure. In addition, any of the described units, modules or components may be implemented together or separately as discrete but interoperable logic devices. Depiction of different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware or software components. Rather, functionality associated with one or more modules or units may be performed by separate hardware or software components, or integrated within common or separate hardware or software components.
- There are a variety of other embodiments that can be employed for the pre-specified window used in
FIG. 15 . For example, the pre-specified window can be set to begin at an atrial wave marker and extend a certain length of time or to another marker. In yet another embodiment, the pre-specified window can be set to begin at a ventricular wave marker and extend a certain length of time or to another marker. - When implemented in software, the functionality ascribed to the systems, devices and techniques described in this disclosure may be embodied as instructions on a computer-readable medium such as random access memory (RAM), read-only memory (ROM), non-volatile random access memory (NVRAM), electrically erasable programmable read-only memory (EEPROM), FLASH memory, magnetic data storage media, optical data storage media, or the like. The instructions may be executed to support one or more aspects of the functionality described in this disclosure.
Claims (21)
1. A method of cardiac pacing comprising:
a) determining a baseline rhythm using a plurality of body-surface electrodes, the baseline rhythm includes an atrial marker and a ventricular marker (Vs);
b) defining a pre-specified window between the atrial marker and the ventricular marker;
c) applying a low pass filter to a signal within the window;
d) determining a rectified slope of the signal;
e) determining a time point (t1) in which the rectified slope exceeds 10% of a maximum value of the rectified slope;
f) determining a point of onset of a depolarization complex in the signal;
g) determine an electromechanical delay for each of a plurality of candidate cardiac pacing lead sites using the determined point of onset of the depolarization complex; and
h) select an implant site for a pacing lead for delivering cardiac pacing based upon the determined electromechanical delays.
2. The method of claim 1 wherein automated determination of the point of onset of the depolarization complex is performed without detection of a threshold.
3. The method of claim 1 wherein the largest curvature in the signal is determined from a curvature of the signal defined as r=|y″|/(1+|y′|2)(3/2) in which y″ and y′ are the double and single derivatives of y=f(t), respectively.
4. The method of claim 1 wherein a simplified version of a curvature equation, r≈|y″|/(1+|y′|2), may be used to compute an index that tracks the curvature of the signal, eliminating computation of square roots.
5. The method of claim 2 wherein determining the point of onset of the depolarization complex comprises searching for the largest curvature of the signal or an index tracking a curvature of the signal at a sharp deflection in the curvature of the signal, the sharp deflection being indicative of the onset of the depolarization complex.
6. The method of claim 1 further comprising: searching for the largest curvature within the pre-specified window and ending on a maximum peak or a minimum valley.
7. The method of claim 1 further comprising: removing high-frequency artifacts in the signal through the low pass filter.
8. The method of claim 1 further comprising:
receiving an ECG signal by a cardiac resynchronization therapy (CRT) device,
wherein determining the point of onset of the depolarization complex comprises determining a point of onset of a QRS complex in the ECG signal received by the CRT device.
9. The method of claim 18 wherein receiving the ECG signal by the CRT device includes receiving one of a leadless ECG signal and a far-field ECG signal.
10. The method of claim 8 further comprising:
automating measurements of cardiac electrical activation times with respect to the determined point of onset of the QRS complex.
11. A system of cardiac pacing comprising:
a) processing means for determining a baseline rhythm using a plurality of body-surface electrodes, the baseline rhythm includes an atrial marker and a ventricular marker (Vs);
b) processing means for defining a pre-specified window between the atrial marker and the ventricular marker;
c) processing means for applying a low pass filter to a signal within the window;
d) processing means for determining a rectified slope of the signal;
e) processing means for determining a time point (t1) in which the rectified slope exceeds 10% of a maximum value of the rectified slope;
f) processing means for determining a point of onset of a depolarization complex in the signal, wherein the point of onset occurs at a largest curvature in the signal;
g) processing means for determining an electromechanical delay for each of a plurality of candidate cardiac pacing lead sites using the determined point of onset of the depolarization complex; and
h) processing means for selecting an implant site for a pacing lead for delivering cardiac pacing based upon the determined electromechanical delays.
12. The system of claim 11 wherein automated determination of the point of onset of the depolarization is performed without detection of a threshold.
13. The system of claim 11 wherein the largest curvature in the signal is determined from a curvature in the signal defined as r=|y″|/(1+|y′|2)(3/2) in which y″ and y′ are the double and single derivatives of y=f(t), respectively.
14. The system of claim 11 wherein a simplified version of a curvature equation r≈|y″|/(1+|y′|2), may be used to compute an index that tracks the curvature of the signal thereby eliminating computation of square roots.
15. The system of claim 12 wherein determining the point of onset of the depolarization complex comprises searching for the largest curvature in the signal or an index tracking a curvature of the signal at a sharp deflection in the curvature of the signal, the sharp deflection being indicative of the onset of the depolarization complex.
16. The system of claim 11 further comprising: processing means for searching for the largest curvature within the pre-specified window and ending on a maximum peak or a minimum valley.
17. The system of claim 11 further comprising: removing high-frequency artifacts in the signal through the low pass filter.
18. The system of claim 11 further comprising:
receiving means for receiving an ECG signal by a cardiac resynchronization therapy (CRT) device
wherein determining the point of onset of the depolarization complex comprises determining a point of onset of a QRS complex in the ECG signal received by the CRT device.
19. The system of claim 18 wherein the receiving means for receiving the ECG signal by the CRT device includes means for receiving one of a leadless ECG signal and a far-field ECG signal.
20. The system of claim 18 further comprising: processing means for automating measurements of cardiac electrical activation times with respect to the determined point of onset of the QRS complex.
21-27. (canceled)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/853,640 US20160067498A1 (en) | 2013-07-26 | 2015-09-14 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
US15/368,199 US10449365B2 (en) | 2013-07-26 | 2016-12-02 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/952,076 US9132274B2 (en) | 2013-07-26 | 2013-07-26 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
US14/853,640 US20160067498A1 (en) | 2013-07-26 | 2015-09-14 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/952,076 Continuation US9132274B2 (en) | 2013-07-26 | 2013-07-26 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/368,199 Continuation US10449365B2 (en) | 2013-07-26 | 2016-12-02 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160067498A1 true US20160067498A1 (en) | 2016-03-10 |
Family
ID=51355634
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/952,076 Active 2033-09-21 US9132274B2 (en) | 2013-07-26 | 2013-07-26 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
US14/853,640 Abandoned US20160067498A1 (en) | 2013-07-26 | 2015-09-14 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
US15/368,199 Active 2034-01-31 US10449365B2 (en) | 2013-07-26 | 2016-12-02 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/952,076 Active 2033-09-21 US9132274B2 (en) | 2013-07-26 | 2013-07-26 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/368,199 Active 2034-01-31 US10449365B2 (en) | 2013-07-26 | 2016-12-02 | Determining onsets and offsets of cardiac depolarization and repolarization waves |
Country Status (4)
Country | Link |
---|---|
US (3) | US9132274B2 (en) |
EP (1) | EP3024386B1 (en) |
CN (1) | CN105578955B (en) |
WO (1) | WO2015013541A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9610045B2 (en) | 2015-07-31 | 2017-04-04 | Medtronic, Inc. | Detection of valid signals versus artifacts in a multichannel mapping system |
US9737223B2 (en) * | 2015-05-13 | 2017-08-22 | Medtronic, Inc. | Determining onset of cardiac depolarization and repolarization waves for signal processing |
US9782094B2 (en) | 2015-07-31 | 2017-10-10 | Medtronic, Inc. | Identifying ambiguous cardiac signals for electrophysiologic mapping |
US11419539B2 (en) | 2017-12-22 | 2022-08-23 | Regents Of The University Of Minnesota | QRS onset and offset times and cycle selection using anterior and posterior electrode signals |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9931048B2 (en) | 2013-04-30 | 2018-04-03 | Medtronic, Inc. | Systems, methods, and interfaces for identifying effective electrodes |
US9132274B2 (en) | 2013-07-26 | 2015-09-15 | Medtronic, Inc. | Determining onsets and offsets of cardiac depolarization and repolarization waves |
US9986928B2 (en) | 2013-12-09 | 2018-06-05 | Medtronic, Inc. | Noninvasive cardiac therapy evaluation |
US10959618B2 (en) * | 2014-05-12 | 2021-03-30 | The Johns Hopkins University | Imaging toolbox for guiding cardiac resynchronization therapy implantation from patient-specific imaging and body surface potential mapping data |
US9750941B2 (en) | 2015-01-23 | 2017-09-05 | Medtronic, Inc. | Criteria for determination of local tissue latency near pacing lead electrodes |
CN108289631B (en) * | 2015-10-07 | 2021-03-02 | 圣犹达医疗用品心脏病学部门有限公司 | Method and system for mapping cardiac repolarization |
US11219769B2 (en) | 2016-02-26 | 2022-01-11 | Medtronic, Inc. | Noninvasive methods and systems of determining the extent of tissue capture from cardiac pacing |
US10780279B2 (en) | 2016-02-26 | 2020-09-22 | Medtronic, Inc. | Methods and systems of optimizing right ventricular only pacing for patients with respect to an atrial event and left ventricular event |
WO2017189594A1 (en) * | 2016-04-26 | 2017-11-02 | Cipriano Emiliano | Pet bed covering system |
CN109071850B (en) | 2016-05-12 | 2021-04-27 | 沙特基础工业全球技术有限公司 | Capacitor film with high temperature resistance, manufacturing method thereof and product thereof |
US10610132B2 (en) * | 2016-08-02 | 2020-04-07 | Medtronic, Inc. | Step detection using accelerometer axis |
US10383534B2 (en) * | 2016-08-11 | 2019-08-20 | Biosense Webster (Israel) Ltd. | Annotation of a wavefront |
US10532213B2 (en) | 2017-03-03 | 2020-01-14 | Medtronic, Inc. | Criteria for determination of local tissue latency near pacing electrode |
US10881862B2 (en) | 2017-05-10 | 2021-01-05 | Medtronic, Inc. | Estimating RV-timings from left ventricular (LV) sensing times for adaptive cardiac resynchronization therapy using DDD/VDD LV pacing without a right ventricular (RV) lead |
WO2019023472A1 (en) | 2017-07-28 | 2019-01-31 | Medtronic, Inc. | Generating activation times |
WO2019023478A1 (en) | 2017-07-28 | 2019-01-31 | Medtronic, Inc. | Cardiac cycle selection |
CN107714027B (en) * | 2017-11-09 | 2020-11-03 | 杭州质子科技有限公司 | Electrocardiosignal processing method based on signal segmentation smoothing |
US11278727B2 (en) | 2017-11-22 | 2022-03-22 | Medtronic, Inc. | Efficient delivery of multi-site pacing |
US10939875B2 (en) | 2018-01-26 | 2021-03-09 | Fujitsu Limited | Optimized real peak detection in cyclic biological data signals |
CN111867506A (en) * | 2018-02-05 | 2020-10-30 | 梅奥医学教育与研究基金会 | System and method for mapping and modulating repolarization |
JP7186395B2 (en) * | 2019-01-25 | 2022-12-09 | 国立大学法人滋賀医科大学 | Recording device, recording method and program |
US11944461B2 (en) | 2019-12-02 | 2024-04-02 | Medtronic, Inc. | Generating representative cardiac information |
WO2022192629A1 (en) * | 2021-03-12 | 2022-09-15 | Cardioinsight Technologies Inc. | Late activation of cardiac signals |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374382A (en) | 1981-01-16 | 1983-02-15 | Medtronic, Inc. | Marker channel telemetry system for a medical device |
JPS60222032A (en) | 1984-04-19 | 1985-11-06 | 日本電気株式会社 | Electrocardiograph signal processor |
JP2820721B2 (en) | 1989-06-23 | 1998-11-05 | フクダ電子株式会社 | QRS detector |
US5117824A (en) | 1990-11-14 | 1992-06-02 | Medtronic, Inc. | Apparatus for monitoring electrical physiologic signals |
US5545186A (en) | 1995-03-30 | 1996-08-13 | Medtronic, Inc. | Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias |
DE69702845T2 (en) | 1996-05-14 | 2000-12-21 | Medtronic Inc | DEVICE RELATING TO PRIORITY RULES FOR DIAGNOSIS AND TREATMENT OF HEART ARHYTHMIA |
US5903664A (en) * | 1996-11-01 | 1999-05-11 | General Electric Company | Fast segmentation of cardiac images |
US5697378A (en) | 1996-12-16 | 1997-12-16 | Siemens Medical Systems, Inc. | Method and apparatus for using multiple leads for QRS detection |
US6684100B1 (en) | 2000-10-31 | 2004-01-27 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
US7792571B2 (en) | 2003-06-27 | 2010-09-07 | Cardiac Pacemakers, Inc. | Tachyarrhythmia detection and discrimination based on curvature parameters |
CN1846231A (en) | 2003-07-21 | 2006-10-11 | 派昂公司 | Method and system for identifying optimal image within a series of images that depict a moving organ |
US7894898B2 (en) * | 2006-06-15 | 2011-02-22 | Medtronic, Inc. | System and method for ventricular interval smoothing following a premature ventricular contraction |
US8260406B2 (en) | 2006-11-30 | 2012-09-04 | Aalborg Universitet | System and method for analyzing complex curvature of ECG curves |
US7706879B2 (en) | 2007-04-30 | 2010-04-27 | Medtronic, Inc. | Apparatus and methods for automatic determination of a fusion pacing pre-excitation interval |
US9943244B2 (en) | 2007-09-14 | 2018-04-17 | Angel Medical Systems, Inc. | Waveform feature value averaging system and methods for the detection of cardiac events |
US20090076404A1 (en) | 2007-09-14 | 2009-03-19 | Bruce Hopenfeld | System and methods for analyzing QRS curvature to detect cardiac events |
US9986926B2 (en) | 2007-10-26 | 2018-06-05 | Inovise Medical, Inc. | Q-onset ventricular depolarization detection in the presence of a pacemaker |
US9566013B2 (en) * | 2008-03-13 | 2017-02-14 | Medtronic, Inc. | Methods and apparatus for monitoring P-wave duration and end and QRS duration with an implantable medical device |
US8478388B2 (en) | 2009-04-07 | 2013-07-02 | Pacesetter, Inc. | Cardiac coordinate system for motion analysis |
US8886313B2 (en) | 2009-07-02 | 2014-11-11 | Cardiac Pacemakers Inc. | Systems and methods for ranking and selection of pacing vectors |
US8972228B2 (en) | 2011-05-03 | 2015-03-03 | Medtronic, Inc. | Assessing intra-cardiac activation patterns |
US9132274B2 (en) | 2013-07-26 | 2015-09-15 | Medtronic, Inc. | Determining onsets and offsets of cardiac depolarization and repolarization waves |
-
2013
- 2013-07-26 US US13/952,076 patent/US9132274B2/en active Active
-
2014
- 2014-07-24 WO PCT/US2014/048070 patent/WO2015013541A1/en active Application Filing
- 2014-07-24 CN CN201480053416.8A patent/CN105578955B/en active Active
- 2014-07-24 EP EP14752478.9A patent/EP3024386B1/en active Active
-
2015
- 2015-09-14 US US14/853,640 patent/US20160067498A1/en not_active Abandoned
-
2016
- 2016-12-02 US US15/368,199 patent/US10449365B2/en active Active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9737223B2 (en) * | 2015-05-13 | 2017-08-22 | Medtronic, Inc. | Determining onset of cardiac depolarization and repolarization waves for signal processing |
US9610045B2 (en) | 2015-07-31 | 2017-04-04 | Medtronic, Inc. | Detection of valid signals versus artifacts in a multichannel mapping system |
US9782094B2 (en) | 2015-07-31 | 2017-10-10 | Medtronic, Inc. | Identifying ambiguous cardiac signals for electrophysiologic mapping |
US10687722B2 (en) | 2015-07-31 | 2020-06-23 | Medtronic, Inc. | Identifying ambiguous cardiac signals for electrophysiologic mapping |
US11419539B2 (en) | 2017-12-22 | 2022-08-23 | Regents Of The University Of Minnesota | QRS onset and offset times and cycle selection using anterior and posterior electrode signals |
Also Published As
Publication number | Publication date |
---|---|
EP3024386A1 (en) | 2016-06-01 |
WO2015013541A1 (en) | 2015-01-29 |
CN105578955B (en) | 2019-03-22 |
US20150032014A1 (en) | 2015-01-29 |
US9132274B2 (en) | 2015-09-15 |
EP3024386B1 (en) | 2017-09-06 |
US20170143976A1 (en) | 2017-05-25 |
US10449365B2 (en) | 2019-10-22 |
CN105578955A (en) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10449365B2 (en) | Determining onsets and offsets of cardiac depolarization and repolarization waves | |
US10687722B2 (en) | Identifying ambiguous cardiac signals for electrophysiologic mapping | |
EP3328485B1 (en) | Detection of valid signals versus artifacts in a multichannel mapping system | |
EP3294123B1 (en) | Determining onset of cardiac depolarization and repolarization waves for signal processing | |
US9572505B2 (en) | Determining onsets and offsets of cardiac depolarization and repolarization waves | |
US11712188B2 (en) | Posterior left bundle branch engagement | |
US20210308458A1 (en) | Cardiac conduction system engagement | |
US11911168B2 (en) | Cardiac conduction system therapy benefit determination | |
US10918863B2 (en) | Generating activation times | |
US20220168576A1 (en) | Evaluation and adjustment of left bundle branch (lbb) pacing therapy | |
US11813464B2 (en) | Cardiac conduction system evaluation | |
EP4255557A1 (en) | Evaluation and adjustment of left bundle branch (lbb) pacing therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GHOSH, SUBHAM;REEL/FRAME:037169/0387 Effective date: 20130726 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |